Lung cancer, Non small cell lung cancer (NSCLC)
Open
Phase 1
This trial is to find the best dose of certain targeted drugs to give alongside radiotherapy for people with non small cell lung cancer (NSCLC).
It is for people whose lung cancer hasn’t spread further than the chest. This is called localised lung cancer.
Cancer Research UK supports this trial.
Recruitment start: 17 March 2021
Recruitment end: 31 March 2026
Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.
Dr Alastair Greystoke
Prof Corinne Faivre-Finn
Cancer Research UK
AstraZeneca
Leeds Teaching Hospitals NHS Trust
Newcastle University
University of Glasgow
University of Leeds
University of Manchester
This is Cancer Research UK trial number CRUK/19/006.
Last reviewed: 13 July 2025
CRUK internal database number: 16687
About Cancer generously supported by Dangoor Education since 2010. Learn more about Dangoor Education
What to ask your doctor about clinical trials.
Meet and chat to other cancer people affected by cancer.
Questions about cancer? Call freephone 0808 800 40 40 from 9 to 5 - Monday to Friday. Alternatively, you can email us.
